Home > Treatment Options > Tumor Suppressors > Clinical Trials >

Koselugo (Selumetinib)

Last Updated: 12/19/20

Plexiform Neurofibromas

Medscape. "FDA Approves Koselugo for Pediatric Neurofibromatosis Treatment." (2020) https://www.medscape.com/viewarticle/928598
What is NF2? | About Us | Treatment Options | Sitemap

Site Search

Disclaimer: Neurofibromatosis Type 2 - Information and Services, www.nf2is.org, is not run by medical experts, affiliated with any healthcare organization or any other company. No assurance can be made to the accuracy or completeness of the information provided here, the accuracy of other sites to which this site links, or of sites that link to this site. - Read More

Copyright © 2021